Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by MediciNova
Sponsor:
Collaborators:
National Multiple Sclerosis Society
Information provided by (Responsible Party):
MediciNova
ClinicalTrials.gov Identifier:
NCT01982942
First received: October 29, 2013
Last updated: July 25, 2014
Last verified: July 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)